Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 4, 2012, Pages 943-956

  de Souza, Paloma Silva ^a   da Cunha Vasconcelos, Flavia ^b   Silva, Luis Felipe R ^b   Maia, Raquel Ciuvalschi ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN K 562; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; P-GLYCOPROTEIN; VINCRISTINE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 85027942829     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0323-5     Document Type: Article

References (0)